US Stock MarketDetailed Quotes

Collegium Pharmaceutical (COLL)

Watchlist
  • 34.830
  • -0.040-0.11%
Close May 14 15:59 ET
  • 34.830
  • 0.0000.00%
Post 16:10 ET
1.13BMarket Cap16.91P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Collegium Pharmaceutical (COLL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
8.87%193.52M
23.62%780.57M
12.92%205.45M
31.42%209.36M
29.41%188M
22.66%177.76M
11.41%631.45M
21.51%181.95M
16.53%159.3M
7.18%145.28M
Operating revenue
8.87%193.52M
23.62%780.57M
12.92%205.45M
31.42%209.36M
29.41%188M
22.66%177.76M
11.41%631.45M
21.51%181.95M
16.53%159.3M
7.18%145.28M
Cost of revenue
-5.17%76.27M
24.87%317.31M
-7.88%77.07M
28.29%80.19M
46.16%79.62M
50.43%80.43M
5.61%254.11M
51.79%83.66M
10.83%62.51M
-11.75%54.47M
Gross profit
20.47%117.25M
22.77%463.26M
30.61%128.38M
33.45%129.17M
19.36%108.38M
6.42%97.32M
15.69%377.34M
3.87%98.29M
20.52%96.79M
23.00%90.81M
Operating expense
12.99%86.35M
35.39%284.8M
7.21%67.64M
8.31%67.1M
69.93%73.64M
82.04%76.42M
32.13%210.36M
91.52%63.09M
75.52%61.96M
13.46%43.34M
Selling and administrative expenses
12.99%86.35M
35.39%284.8M
7.21%67.64M
8.31%67.1M
69.93%73.64M
82.04%76.42M
32.13%210.36M
91.52%63.09M
75.52%61.96M
13.46%43.34M
Research and development costs
----
----
----
----
----
----
--0
----
----
----
Operating profit
47.82%30.9M
6.87%178.45M
72.57%60.74M
78.16%62.07M
-26.80%34.75M
-57.75%20.9M
0.01%166.98M
-42.94%35.2M
-22.60%34.84M
33.22%47.47M
Net non-operating interest income expense
34.52%-12.16M
-18.38%-71.02M
24.54%-15.73M
-23.40%-18.65M
-61.57%-18.08M
-44.45%-18.57M
11.41%-60M
-39.15%-20.84M
6.88%-15.11M
37.26%-11.19M
Non-operating interest income
66.56%3.71M
-19.23%11.29M
96.74%3.57M
-5.00%3.12M
-45.80%2.38M
-50.41%2.23M
-10.50%13.98M
-57.89%1.81M
-27.72%3.28M
9.19%4.4M
Non-operating interest expense
-23.70%15.86M
11.27%82.31M
-14.84%19.29M
18.34%21.77M
31.28%20.46M
19.90%20.79M
-11.24%73.97M
17.49%22.65M
-11.43%18.39M
-28.71%15.59M
Other net income (expense)
-76.02%-14.81M
-648.22%-15.98M
100.46%19K
104.98%358K
786K
64.20%-8.42M
2.91M
-4.15M
-7.18M
Special income (charges)
--0
-76.02%-14.81M
-648.22%-15.98M
100.46%19K
104.98%358K
--786K
64.20%-8.42M
--2.91M
---4.15M
---7.18M
-Less：Restructuring and merger&acquisition
--0
59.44%-1.18M
99.35%-19K
---19K
---358K
---786K
---2.91M
---2.91M
--0
--0
-Less:Other special charges
----
41.18%15.99M
----
----
----
----
-51.80%11.33M
--0
--4.15M
--7.18M
Income before tax
500.26%18.74M
-6.04%92.62M
68.14%29.04M
178.79%43.44M
-41.49%17.03M
-91.48%3.12M
30.15%98.57M
-63.03%17.27M
-45.87%15.58M
63.49%29.1M
Income tax
501.99%4.24M
1.26%29.75M
155.08%12.07M
91.02%11.93M
-46.88%5.04M
-92.09%705K
6.53%29.38M
-67.96%4.73M
-23.36%6.25M
98.14%9.49M
Net income
499.75%14.5M
-9.13%62.87M
35.31%16.96M
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
Net income continuous Operations
499.75%14.5M
-9.13%62.87M
35.31%16.96M
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
Minority interest income
Net income attributable to the parent company
499.75%14.5M
-9.13%62.87M
35.31%16.96M
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
499.75%14.5M
-9.13%62.87M
35.31%16.96M
237.51%31.51M
-38.88%11.98M
-91.28%2.42M
43.68%69.19M
-60.75%12.54M
-54.76%9.34M
50.73%19.61M
Basic earnings per share
462.50%0.45
-7.48%1.98
38.46%0.54
244.83%1
-36.67%0.38
-90.70%0.08
49.65%2.14
-59.38%0.39
-52.46%0.29
57.89%0.6
Diluted earnings per share
471.43%0.4
-6.99%1.73
27.78%0.46
211.11%0.84
-34.62%0.34
-90.14%0.07
44.19%1.86
-56.63%0.36
-49.06%0.27
52.94%0.52
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 8.87%193.52M23.62%780.57M12.92%205.45M31.42%209.36M29.41%188M22.66%177.76M11.41%631.45M21.51%181.95M16.53%159.3M7.18%145.28M
Operating revenue 8.87%193.52M23.62%780.57M12.92%205.45M31.42%209.36M29.41%188M22.66%177.76M11.41%631.45M21.51%181.95M16.53%159.3M7.18%145.28M
Cost of revenue -5.17%76.27M24.87%317.31M-7.88%77.07M28.29%80.19M46.16%79.62M50.43%80.43M5.61%254.11M51.79%83.66M10.83%62.51M-11.75%54.47M
Gross profit 20.47%117.25M22.77%463.26M30.61%128.38M33.45%129.17M19.36%108.38M6.42%97.32M15.69%377.34M3.87%98.29M20.52%96.79M23.00%90.81M
Operating expense 12.99%86.35M35.39%284.8M7.21%67.64M8.31%67.1M69.93%73.64M82.04%76.42M32.13%210.36M91.52%63.09M75.52%61.96M13.46%43.34M
Selling and administrative expenses 12.99%86.35M35.39%284.8M7.21%67.64M8.31%67.1M69.93%73.64M82.04%76.42M32.13%210.36M91.52%63.09M75.52%61.96M13.46%43.34M
Research and development costs --------------------------0------------
Operating profit 47.82%30.9M6.87%178.45M72.57%60.74M78.16%62.07M-26.80%34.75M-57.75%20.9M0.01%166.98M-42.94%35.2M-22.60%34.84M33.22%47.47M
Net non-operating interest income expense 34.52%-12.16M-18.38%-71.02M24.54%-15.73M-23.40%-18.65M-61.57%-18.08M-44.45%-18.57M11.41%-60M-39.15%-20.84M6.88%-15.11M37.26%-11.19M
Non-operating interest income 66.56%3.71M-19.23%11.29M96.74%3.57M-5.00%3.12M-45.80%2.38M-50.41%2.23M-10.50%13.98M-57.89%1.81M-27.72%3.28M9.19%4.4M
Non-operating interest expense -23.70%15.86M11.27%82.31M-14.84%19.29M18.34%21.77M31.28%20.46M19.90%20.79M-11.24%73.97M17.49%22.65M-11.43%18.39M-28.71%15.59M
Other net income (expense) -76.02%-14.81M-648.22%-15.98M100.46%19K104.98%358K786K64.20%-8.42M2.91M-4.15M-7.18M
Special income (charges) --0-76.02%-14.81M-648.22%-15.98M100.46%19K104.98%358K--786K64.20%-8.42M--2.91M---4.15M---7.18M
-Less：Restructuring and merger&acquisition --059.44%-1.18M99.35%-19K---19K---358K---786K---2.91M---2.91M--0--0
-Less:Other special charges ----41.18%15.99M-----------------51.80%11.33M--0--4.15M--7.18M
Income before tax 500.26%18.74M-6.04%92.62M68.14%29.04M178.79%43.44M-41.49%17.03M-91.48%3.12M30.15%98.57M-63.03%17.27M-45.87%15.58M63.49%29.1M
Income tax 501.99%4.24M1.26%29.75M155.08%12.07M91.02%11.93M-46.88%5.04M-92.09%705K6.53%29.38M-67.96%4.73M-23.36%6.25M98.14%9.49M
Net income 499.75%14.5M-9.13%62.87M35.31%16.96M237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M
Net income continuous Operations 499.75%14.5M-9.13%62.87M35.31%16.96M237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M
Minority interest income
Net income attributable to the parent company 499.75%14.5M-9.13%62.87M35.31%16.96M237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 499.75%14.5M-9.13%62.87M35.31%16.96M237.51%31.51M-38.88%11.98M-91.28%2.42M43.68%69.19M-60.75%12.54M-54.76%9.34M50.73%19.61M
Basic earnings per share 462.50%0.45-7.48%1.9838.46%0.54244.83%1-36.67%0.38-90.70%0.0849.65%2.14-59.38%0.39-52.46%0.2957.89%0.6
Diluted earnings per share 471.43%0.4-6.99%1.7327.78%0.46211.11%0.84-34.62%0.34-90.14%0.0744.19%1.86-56.63%0.36-49.06%0.2752.94%0.52
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.75%
Sample Name
Sample Code
 +15.52%
Sample Name
Sample Code
 +14.53%
4
United States Oil Fund LP
USO
+13.64%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.14%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +9.49%
Sample Name
Sample Code
 +8.77%
4
Hesai
HSAI
+8.01%
5
NIO Inc
NIO
+6.47%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -